Statistical Assessment of Biosimilar Products
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2009/12/31
-
Indian UGC (journal)
-
Refrences47
-
Citations22
-
Shein-Chung Chow a Duke University School of Medicine , Durham , North Carolina , USAd Statistics Department , National Cheng Kung University , Tainan , Taiwan
-
Jen-pei Liu b Division of Biometry, Department of Agronomy , National Taiwan University , Taipei , Taiwanc Division of Biostatistics and Bioinformatics , National Health Research Institutes , Zhunan , Taiwan
Cite
Chow, Shein-Chung, and Jen-pei Liu. “Statistical Assessment of Biosimilar Products”. Journal of Biopharmaceutical Statistics, vol. 20, no. 1, 2009, pp. 10-30, https://doi.org/10.1080/10543400903280266.
Chow, S.-C., & Liu, J.- pei. (2009). Statistical Assessment of Biosimilar Products. Journal of Biopharmaceutical Statistics, 20(1), 10-30. https://doi.org/10.1080/10543400903280266
Chow SC, Liu J pei. Statistical Assessment of Biosimilar Products. Journal of Biopharmaceutical Statistics. 2009;20(1):10-3.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Mathematics
Probabilities
Mathematical statistics
You May Also Like
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies
- Sample size of 12 per group rule of thumb for a pilot study
- Guidelines for accurate EC50/IC50 estimation
- Quantifying heterogeneity in a meta‐analysis
- Multiple imputation using chained equations: Issues and guidance for practice
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| In Vitro/In Vivo Correlations | Drug Information Journal | 29 | 1995 | |
| 10.1201/9781420011678 | 2008 | |||
| 10.1201/9781420011678 | Journal of the Formosan Medical Association |
| 2008 | |
| 10.1201/9781420011678 | 2007 | |||
| 10.1201/9781420011678 | 1996 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints | Statistics in Medicine |
| 2022 | |
Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study | Molecules |
| 2 | 2022 |
| The determination of biosimilarity margin and the assessment of biosimilarity for an (m+1)-arm parallel design | Communications in Statistics - Theory and Methods |
| 1 | 2020 |
| A Tolerance Interval Approach to Assessing the Biosimilarity of Follow-On Biologics | Statistics in Biopharmaceutical Research |
| 1 | 2017 |
| Evaluation of Bioequivalence of Two Long-Acting 20% Oxytetracycline Formulations in Pigs | Frontiers in Veterinary Science |
| 10 | 2017 |
Citations Analysis
The category
Science: Mathematics: Probabilities. Mathematical statistics 17
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Biosimilars 2.0 and was published in 2011. The most recent citation comes from a 2022 study titled BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints. This article reached its peak citation in 2012, with 6 citations. It has been cited in 10 different journals, 30% of which are open access. Among related journals, the Statistics in Medicine cited this research the most, with 7 citations. The chart below illustrates the annual citation trends for this article.